Dognosis
Tracked across 1 events · 8 articles · First seen Aug 14, 2026 · Last active Aug 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Bengaluru-based startup Dognosis is developing a low-cost, non-invasive cancer prescreening method that uses trained dogs' sense of smell combined with AI and sensors to detect cancer from breath samples. The company reported roughly 90% sensitivity…
Impact: Dognosis is the central entity, developing and testing the canine-AI cancer screening technology. Its Phase 3 trial and planned product launch could position it as a leader in low-cost cancer prescreening, with potential for significant growth.
Aug 14, 2026 · 8 articles
90
Dognosis launched Phase 3 trialDognosis canine cancer...
85
Dognosis raised pre-seedDognosis canine cancer...
80
Dognosis reported sensitivityDognosis canine cancer...
75
Dognosis plans to launchDognosis canine cancer...
60
Dognosis plans US facility United StatesDognosis canine cancer...
ERGEN INTELLIGENCE
Track Dognosis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard